O-specific polysaccharide confers lysozyme resistance to extraintestinal pathogenic Escherichia coli

References

• Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol. 1975;28:124–32. doi:10.1136/jcp.28.2.124
   PubMed Web of Science ®Google Scholar
• Yang CT, Cambier CJ, Davis JM, et al. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe. 2012;12:301–12. doi:10.1016/j.chom.2012.07.009
   PubMed Web of Science ®Google Scholar
• Callewaert L, Michiels CW. Lysozymes in the animal kingdom. J Biosci. 2010;35:127–60. doi:10.1007/s12038-010-0015-5
   PubMed Web of Science ®Google Scholar
• Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun. 1985;48:720–8.
   PubMed Web of Science ®Google Scholar
• Derde M, Guerin-Dubiard C, Lechevalier V, et al. Dry-heating of lysozyme increases its activity against Escherichia coli membranes. J Agric Food Chem. 2014;62:1692–700. doi:10.1021/jf405155p
   PubMed Web of Science ®Google Scholar
• Derde M, Nau F, Lechevalier V, et al. Native lysozyme and dry-heated lysozyme interactions with membrane lipid monolayers: lateral reorganization of LPS monolayer, model of the Escherichia coli outer membrane. Biochim Biophys Acta. 2015;1848:174–83. doi:10.1016/j.bbamem.2014.10.026
   PubMed Web of Science ®Google Scholar
• During K, Porsch P, Mahn A, et al. The non-enzymatic microbicidal activity of lysozymes. FEBS Lett. 1999;449:93–100. doi:10.1016/S0014-5793(99)00405-6
   PubMed Web of Science ®Google Scholar
• Nash JA, Ballard TN, Weaver TE, et al. The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol. 2006;177:519–26. doi:10.4049/jimmunol.177.1.519
   PubMed Web of Science ®Google Scholar
• Davis KM, Weiser JN. Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun. 2011;79:562–70. doi:10.1128/IAI.00651-10
   PubMed Web of Science ®Google Scholar
• Callewaert L, Van Herreweghe JM, Vanderkelen L, et al. Guards of the great wall: bacterial lysozyme inhibitors. Trends Microbiol. 2012;20:501–10. doi:10.1016/j.tim.2012.06.005
   PubMed Web of Science ®Google Scholar
• Bera A, Biswas R, Herbert S, et al. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 2007;189:280–3. doi:10.1128/JB.01221-06
   PubMed Web of Science ®Google Scholar
• Bera A, Herbert S, Jakob A, et al. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol. 2005;55:778–87. doi:10.1111/j.1365-2958.2004.04446.x
   PubMed Web of Science ®Google Scholar
• Monchois V, Abergel C, Sturgis J, et al. Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J Biol Chem. 2001;276:18437–41. doi:10.1074/jbc.M010297200
   PubMed Web of Science ®Google Scholar
• Callewaert L, Aertsen A, Deckers D, et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog. 2008;4:e1000019. doi:10.1371/journal.ppat.1000019
   PubMed Web of Science ®Google Scholar
• Vanderkelen L, Van Herreweghe JM, Vanoirbeek KG, et al. Identification of a bacterial inhibitor against g-type lysozyme. Cell Mol Life Sci. 2011;68:1053–64. doi:10.1007/s00018-010-0507-3
   PubMed Web of Science ®Google Scholar
• Van Herreweghe JM, Vanderkelen L, Callewaert L, et al. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme. Cell Mol Life Sci. 2010;67:1177–88. doi:10.1007/s00018-009-0241-x
   PubMed Web of Science ®Google Scholar
• Li M, Le Trong I, Carl MA, et al. Structural basis for type VI secretion effector recognition by a cognate immunity protein. PLoS Pathog. 2012;8:e1002613. doi:10.1371/journal.ppat.1002613
   PubMed Web of Science ®Google Scholar
• Ohno N, Morrison DC. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J Biol Chem. 1989;264:4434–41.
   PubMed Web of Science ®Google Scholar
• Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. PNAS. 2010;107:9072–7. doi:10.1073/pnas.0915077107
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez L, Geeraerd AH, Mast J, et al. Membrane permeabilization and cellular death of Escherichia coli, Listeria monocytogenes and Saccharomyces cerevisiae as induced by high pressure carbon dioxide treatment. Food Microbiol. 2010;27:541–9. doi:10.1016/j.fm.2009.12.004
   PubMed Web of Science ®Google Scholar
• Moyo B, Mukanganyama S. Antibacterial Effects of Cissus welwitschii and Triumfetta welwitschii Extracts against Escherichia coli and Bacillus cereus. Int J Bacteriol. 2015;2015:162028.
   PubMedGoogle Scholar
• Miki T, Holst O, Hardt WD. The bactericidal activity of the C-type lectin RegIIIbeta against Gram-negative bacteria involves binding to lipid A. J Biol Chem. 2012;287:34844–55. doi:10.1074/jbc.M112.399998
   PubMed Web of Science ®Google Scholar
• Ma J, Sun M, Bao Y, et al. Genetic diversity and features analysis of type VI secretion systems loci in avian pathogenic Escherichia coli by wide genomic scanning. Infect Genet Evol. 2013;20:454–64. doi:10.1016/j.meegid.2013.09.031
   PubMed Web of Science ®Google Scholar
• Brandenburg K, Koch MH, Seydel U. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur J Biochem. 1998;258:686–95. doi:10.1046/j.1432-1327.1998.2580686.x
   PubMedGoogle Scholar
• Santos NC, Silva AC, Castanho MA, et al. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem. 2003;4:96–100. doi:10.1002/cbic.200390020
   PubMed Web of Science ®Google Scholar
• Masschalck B, Michiels CW. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit Rev Microbiol. 2003;29:191–214. doi:10.1080/713610448
   PubMed Web of Science ®Google Scholar
• Romanini D, Braia M, Angarten RG, et al. Interaction of lysozyme with negatively charged flexible chain polymers. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;857:25–31. doi:10.1016/j.jchromb.2007.06.025
   PubMed Web of Science ®Google Scholar
• Derde M, Lechevalier V, Guerin-Dubiard C, et al. Hen egg white lysozyme permeabilizes Escherichia coli outer and inner membranes. J Agric Food Chem. 2013;61:9922–9. doi:10.1021/jf4029199
   PubMed Web of Science ®Google Scholar
• Vanderkelen L, Van Herreweghe JM, Callewaert L, et al. Goose-type lysozyme inhibitor (PliG) enhances survival of Escherichia coli in goose egg albumen. Appl Environ Microbiol. 2011;77:4697–9. doi:10.1128/AEM.00427-11
   PubMed Web of Science ®Google Scholar
• Clarke CA, Scheurwater EM, Clarke AJ. The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J Biol Chem. 2010;285:14843–7. doi:10.1074/jbc.C110.120931
   PubMed Web of Science ®Google Scholar
• Uehara T, Suefuji K, Valbuena N, et al. Recycling of the anhydro-N-acetylmuramic acid derived from cell wall murein involves a two-step conversion to N-acetylglucosamine-phosphate. J Bacteriol. 2005;187:3643–9. doi:10.1128/JB.187.11.3643-3649.2005
   PubMed Web of Science ®Google Scholar
• Tivendale KA, Logue CM, Kariyawasam S, et al. Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun. 2010;78:3412–9. doi:10.1128/IAI.00347-10
   PubMed Web of Science ®Google Scholar
• Li G, Laturnus C, Ewers C, et al. Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect Immun. 2005;73:2818–27. doi:10.1128/IAI.73.5.2818-2827.2005
   PubMed Web of Science ®Google Scholar
• Sambrook JF, Russell DW. Molecular cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
   Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. PNAS. 2000;97:6640–5. doi:10.1073/pnas.120163297
   PubMed Web of Science ®Google Scholar
• Cai W, Wannemuehler Y, Dell'anna G, et al. A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog. 2013;9:e1003428. doi:10.1371/journal.ppat.1003428
   PubMed Web of Science ®Google Scholar
• Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982;119:115–9. doi:10.1016/0003-2697(82)90673-X
   PubMed Web of Science ®Google Scholar
• Deckers D, Vanlint D, Callewaert L, et al. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk. Appl Environ Microbiol. 2008;74:4434–9. doi:10.1128/AEM.00589-08
   PubMed Web of Science ®Google Scholar
• Leyva A, Quintana A, Sanchez M, et al. Rapid and sensitive anthrone-sulfuric acid assay in microplate format to quantify carbohydrate in biopharmaceutical products: method development and validation. Biologicals. 2008;36:134–41. doi:10.1016/j.biologicals.2007.09.001
   PubMed Web of Science ®Google Scholar
• Morrison DC, Leive L. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem. 1975;250:2911–19.
   PubMed Web of Science ®Google Scholar
• Caroff M, Tacken A, Szabo L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the “isolated lipid A” fragment of the Bordetella pertussis endotoxin. Carbohydr Res. 1988;175:273–82. doi:10.1016/0008-6215(88)84149-1
   PubMed Web of Science ®Google Scholar
• Lane MC, Alteri CJ, Smith SN, et al. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. PNAS. 2007;104:16669–74. doi:10.1073/pnas.0607898104
   PubMed Web of Science ®Google Scholar